HomeHCWB • NASDAQ
Hcw Biologics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 5.07K | -99.55% |
Operating expense | 3.97M | -51.08% |
Net income | -2.20M | 70.58% |
Net profit margin | -43.37K | -6,443.80% |
Earnings per share | — | — |
EBITDA | -3.55M | 51.08% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.11M | -72.88% |
Total assets | 26.29M | -13.61% |
Total liabilities | 34.85M | 60.68% |
Total equity | -8.56M | — |
Shares outstanding | 1.44M | — |
Price to book | -27.89 | — |
Return on assets | -35.08% | — |
Return on capital | -161.21% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -2.20M | 70.58% |
Cash from operations | -3.51M | 2.50% |
Cash from investing | — | — |
Cash from financing | -53.10K | -101.26% |
Net change in cash | -3.57M | -829.48% |
Free cash flow | -4.11M | -451.00% |
Previous close
$5.30
Day range
$4.81 - $5.15
Year range
$4.62 - $100.40
Market cap
9.58M USD
Avg Volume
1.37M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2018
Headquarters
Website
Employees
36